von Willebrand disease: Still an intriguing disorder in the era of molecular medicine

Haemophilia

Volumn 8, Issue 3, 2002, Pages 292-300

  Rodeghiero, F ^a  

^a SAN BORTOLO HOSPITAL   (Italy)

Author keywords

Bleeding disorders; von Willebrand disease; von Willebrand factor

Indexed keywords

BLOOD CLOTTING FACTOR 8; DESMOPRESSIN; PROTEIN SUBUNIT; VON WILLEBRAND FACTOR;

AGE; ALLELE; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE INHERITANCE; BLEEDING DISORDER; BLEEDING TIME; BLOOD GROUP ABO SYSTEM; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; DRUG EFFECT; ENVIRONMENTAL FACTOR; FAMILY; GENE DELETION; GENE LOCUS; GENETIC DISORDER; HEREDITY; HUMAN; INFLAMMATION; LABORATORY TEST; MISSENSE MUTATION; NONSENSE MUTATION; PENETRANCE; POPULATION RESEARCH; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; SHEAR STRESS; STRESS; SYMPTOMATOLOGY; THROMBOCYTE ADHESION; VON WILLEBRAND DISEASE; ALGORITHM; BLEEDING; CLASSIFICATION; DIAGNOSTIC PROCEDURE; REVIEW;

ALGORITHMS; HEMORRHAGE; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; VON WILLEBRAND DISEASE;

EID: 0036588833     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.2002.00611.x     Document Type: Article

References (43)

1. Ginsburg D. von Willebrand disease. In: Beutler R, ed. Williams Hematology, 6th edn. New York: McGraw-Hill, 2001: 1813-28.
2. Montgomery RR. Structure and function of von Willebrand factor. . In: Colman et al., eds. Hemostasis and Thrombosis: Basic Principle and Practice, 4th edn. Philadelphia: Lippincott Williams & Wilkins, 2001: 249-74.
3. Sadler JE, Blinder M. von Willebrand disease: diagnosis, classification, and treatment. In: Colman RW et al., eds. Hemostasis and Thrombosis: Basic Principle and Practice, 4th edn. Philadelphia: Lippincott Williams & Wilkins, 2001: 825-37.
4. Romani De Wit T, van Mourik JA. Biosynthesis, processing and secretion of von Willebrand factor: biological implications. Best Pract Res Clin Haematol 2001; 14: 241-55.
5. Ruggeri ZM. Structure of von Willebrand factor and its function in platelet adhesion and thrombus formation. Best Pract Res Clin Haematol 2001; 14: 257-79.
6. Lee CA, Kessler CM, eds. Proceedings of a nordic von Willebrand symposium. Haemophilia 1999; 5 (Suppl. 2).
7. Nilsson IM. The history of von Willebrand disease. Haemophilia 1999; 3 (Suppl. 2): 7-11.
8. Federici AB. Diagnosis of von Willebrand disease. Haemophilia 1998; 4: 654-60.
9. Mannucci PM. How I treat patients with von Willebrand disease. Blood 2001; 97: 1915-9.
10. Lee CA, Brettler DB, eds. Guidelines for the diagnosis and management of von Willebrand Disease. Haemophilia 1997; 3 (Suppl. 2).
11. Goodeve AC, Eikenboom JC, Ginsburg D et al. A standard nomenclature for von Willebrand factor gene mutations and polymorphisms. On behalf of the ISTH SSC Subcommittee on von Willebrand factor. Thromb Haemost 2001; 85: 929-31.
12. Fowler WE, Fretto LJ. Electron microscopy of von Wilebrand factor. In: Zimmerman TS, Ruggeri ZM, eds. Coagulation and Bleeding Disorders: the Role of Factor VIII and von Willebrand Factor New York: Marcel Dekker, 1989: 181-93.
13. Wagner DD. Cell biology of von Willebrand factor. Annu Rev Cell Biol 1990; 6: 217-46.
14. Furlan M, Robles R, Lammle B. Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood 1996; 87: 4223-34.
15. Ruggeri ZM. Old concepts and new developments in the study of platelet aggregation. J Clin Invest 2000; 105: 699-701.
16. Vlot AJ, Koppelman SJ, van den Berg MH et al. The affinity and stoichiometry of binding of human factor VIII to von Willebrand factor. Blood 1995; 85: 3150-7.
17. Sadler JE. A revised classification of von Willebrand disease. For the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 1994; 71: 520-5.
18. Schneppenheim R, Federici AB, Budde U et al. von Willebrand disease type 2M 'Vicenza' in Italian and German patients: identification of the first candidate mutation (G3864A; R1205H) in 8 families. Thromb Haemost 2000; 83: 136-40.
19. Castaman G, Missiaglia E, Federici AB, Schneppenheim R, Rodeghiero F. An additional unique candidate mutation (G2470A; M7401) in the original families with von Willebrand disease type 2 M Vicenza and the G3864A (R1205H) mutation. Thromb Haemost 2000; 84: 350-1.
20. Sadler JE, Mannucci PM, Berntorp E et al. Impact diagnosis and treatment of von Willebrand disease. Thromb Haemost 2000; 84: 160-74.
21. Rodeghiero F, Castaman G. Congenital von Willebrand disease type I. definition, phenotypes, clinical and laboratory assessment. Best Pract Res Clin Haematol 2001; 14: 321-35.
22. Srivastava A, Rodeghiero F. Communication at the SSC Meeting of ISTH, June 16, 2000.
23. Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand's disease. Blood 1987; 69: 454-9.
24. Miller CH, Graham JB, Goldin LR, Elston RC. Genetics of classic von Willebrand's disease. I. Phenotypic variation within families. Blood 1979; 54: 117-36.
25. Eikenboom JC, Matsushita T, Reitsma PH et al. Dominant type 1 von Willebrand disease caused by mutated cysteine residues in the D3 domain of von Willebrand factor. Blood 1996; 88: 2433-41.
26. Bodò I, Katsumi A, Tuley EA, Eikenboom JCJ, Dong Z, Sadler JE. Type I von Willebrand disease mutation Cys1149Arg causes intracellular retention and degradation of heterodimers: a possible general mechanism for dominant mutations of oligomeric proteins. Blood 2001; 98: 2973-9.
27. Castaman G, Eikenboom JC, Missiaglia E, Rodeghiero F. Autosomal dominant type 1 von Willebrand disease due to G3639T mutation (C1130F) in-exon 26 of von Willebrand factor gene: description of five Italian families and evidence for a founder effect. Br J Haematol 2000; 108: 876-9.
28. Nichols WC, Ginsburg D. von Willebrand disease. Medicine 1997; 76: 1-20.
29. Coughlan TC, Blagg JL, Abulola M et al. Null alleles are not a common cause of type 1 von Willebrand disease in the British population. Thromb Haemost 1999; 82: 1373-7.
30. Rodeghiero F, Castaman G, Di Bona E, Ruggeri M, Lombardi R, Mannucci PM. Hyper-responsiveness to DDAVP for patients with type I von Willebrand's disease and normal intra-platelet von Willebrand factor. Eur J Haematol 1988; 40: 163-7.
31. Eikenboom JCJ, Reitsma PH, Peerlinck KMJ, Briet E. Recessive inheritance of von Willebrand's disease type I. Lancet 1993; 341: 982-6.
32. Eikenboom JC, Castaman G, Vos HL, Bertina RM, Rodeghiero F. Characterization of the genetic defects in recessive type 1 and type 3 von Willebrand disease patients of Italian origin. Thromb Haemost 1998; 79: 709-17.
33. Castaman G, Eikenboom JCJ, Bertina R, Rodeghiero F. Inconsistency of association between type I von Willebrand disease phenotype and genotype in families identified in an epidemiological investigation. Thromb Haemost 1999; 82: 1065-70.
34. Nichols WC, Cooney KA, Mohlke KL et al. von Willebrand disease in the RIIIS/J inbred mouse strain as a model for von Willebrand disease. Blood 1994; 83: 3225-8.
35. Mohlke KL, Nichols WC, Westrick RJ et al. A novel modifier gene for plasma von Willebrand factor level maps to distal mouse chromosome 11. Proc Natl Acad Sci U S A 1996; 93: 15352-6.
36. Mohlke KL, Purkayastha AA, Westrick RJ et al. Mvwf, a dominant modifier of murine von Willebrand factor, results from altered lineage-specific expression of a glycosyltransferase. Cell 1998; 96: 111-5.
37. Mohlke KL, Ginsburg D. Von Willebrand disease and quantitative variation in von Willebrand factor. J Lab Clin Med 1997; 130: 252-61.
38. Blomback M, Eneroth P, Andersson O, Anvret M. On laboratory problems in diagnosing mild von Willebrand's disease. Am J Hematol 1992; 40: 117-20.
39. Orstavik KH, Magnus P, Reisner H, Berg K, Graham JB, Nance W. Factor VIII and factor IX in a twin population. Evidence for a major effect of ABO locus on factor VIII level. Am J Hum Genet 1985; 37: 89-101.
40. Gill JC, Endres-Brooks J, Buer PJ et al. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 1987; 69: 1691-5.
41. Rodeghiero F, Castaman G, Tosetto A. von Willebrand factor antigen is less sensitive than ristocetin cofactor for the diagnosis of type I von Willebrand disease - results based on an epidemiological investigation. Thromb Haemost 1990; 64: 349-52.
42. Rodeghiero F, Castaman G, Mannucci PM. Prospective multicenter study on subcutaneous concentrated desmopressin for home treatment of patients with von Willebrand disease and mild or moderate hemophilia A. Thromb Haemost 1996; 76: 692-6.
43. Rodeghiero F, Castaman G, Meyer D, Mannucci PM. Replacement therapy with virus-inactivated plasma concentrates in von Willebrand disease. Vox Sang 1992; 62: 193-9.